The Effect of Cancer Therapies and Exercise on Mitochondrial Energetics and Fitness
NCT01859442 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2014-05-06
Summary
The present study is a randomised control trial investigating the effects of a short six week exercise training program in rectal cancer patients following neoadjuvant chemoradiotherapy prior to elective rectal cancer surgery.
Twelve patients will be randomised (1:1) to an intervention and a control group. The patients randomized to the intervention group will attend a total of 18 tailored exercise sessions (Three 40 minute sessions for six weeks) after their 6 weeks of chemoradiotherapy treatment. Where possible the exercise training sessions will be arranged to fit in with other appointments at the hospital. Patients randomized to the control group will be unsupervised. They will only attend an extra 3 sessions were a cardiopulmonary exercise test and VO2 Kinetics test will be performed. Patients will also be invited to attend 3 health related quality of life interviews at week 0, 3 and 6 during their exercise programme. These appointments will be directly before or after their exercise sessions to minimise hospital attendence.
Following surgery only routine clinically relevant observational data will be collected. These data will relate to hospital length of stay, the level of care required following surgery, post-operative morbidity survey (POMS) and the recovery process. Most of this information can be accessed from patient notes and on the electronic patient records system.
This is a subgroup RCT of patients in a larger interventional trial (6 control and 6 exercise intervention patients) will be asked to consent separately for the the 31-Phosphorus Magnetic Resonance Spectroscopy (31P MRS) scans and the blood samples.
HYPOTHESIS
1. Interval exercise training will maintain or improve fitness (measured by anaerobic threshold) in patients undergoing neoadjuvant chemoradiotherapy.
2. Interval exercise training is safe and feasible in patients undergoing neoadjuvant chemoradiotherapy awaiting rectal cancer resection.
3. Interval exercise training will improve other measures of physical fitness measured in the CPET and the oxygen uptake kinetics test.
4. Interval exercise training will improve quality of life in patients undergoing neoadjuvant chemoradiotherapy.
5. Improvements in physical fitness will reduce postoperative complications following major rectal cancer surgery.
6. Does physical activity, measured by Sensewear Pro 3 activity monitors, decrease during neoadjuvant chemoradiotherapy and can this decrease be attenuated by an exercise training program?
7. Can we find an optimal time for surgery when fitness and cancer downstaging are at their best?
HYPOTHESIS for Mechanism Pilot Study
1. To explore the exponential rate constant of post-exercise phosphocreatine recovery.
2. To explore the alteration in cellular and mitochondrial energetics eg. Change in mitochondrial numbers, change in mitochondrial activity and respiration.
Conditions
- Locally Advanced Rectal Cancer
Interventions
- PROCEDURE
-
Structured responsive interval exercise training programme
- OTHER
-
Sham group
NO intervention in this group, only standard care (no exercise programme)
Sponsors & Collaborators
-
University of Liverpool
collaborator OTHER -
Michelle Mossa
lead OTHER_GOV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2013-07-31
- Completion
- 2013-10-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
The Effects of a 9 Week Exercise Programme on Fitness and Quality of Life in Rectal Cancer Patients After Chemoradiotherapy and Before Surgery
NCT01914068 ·Status: COMPLETED ·Phase: NA
-
Effect of Preoperative Chemoradiotherapy on Exercise Capacity as Measured by Cardiopulmonary Exercise Testing
NCT00833508 ·Status: COMPLETED ·Phase: NA
-
Exercise Training for Rectal Cancer Patients
NCT02538913 ·Status: TERMINATED ·Phase: NA
-
Exercise for Improving Radiotherapy Efficacy in Rectal Cancer
NCT06292975 ·Status: WITHDRAWN ·Phase: NA
-
Prehabilitation During Neoadjuvant Chemoradiotherapy for Rectal Cancer
NCT06542354 ·Status: COMPLETED ·Phase: NA
-
Body Composition Manipulation in CoLorectal cancEr (BiCyCLE): Neuromuscular Electrical Stimulation (NMES)
NCT04065984 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Sarcopenia and Multimodal Rehabilitation on the Prognosis of Rectal Cancer Patients Receiving CCRT
NCT05664607 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Supportive Clinic for Patients Living With Advanced and Metastatic Cancers
NCT06465511 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Microwave Ablation Versus Stereotactic Body Radiotherapy for Colorectal Liver Metastases in Oligometastatic Disease: a Prospective, Randomised, Phase 2 Trial
NCT03654131 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Exercise for Improving Long-course Chemoradiotherapy Efficacy in People With Locally Advanced Rectal Cancer
NCT06276686 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis
NCT03022734 ·Status: UNKNOWN ·Phase: PHASE2
-
Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer
NCT00835055 ·Status: WITHDRAWN
-
A Prospective Study of Expression Profiling-based Assessment of the Efficacy of Neoadjuvant Therapy for Rectal Cancer
NCT06746298 ·Status: NOT_YET_RECRUITING
-
An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)
NCT05340231 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
The Effect of Multimodal Treatment of Rectal Cancer on Circulating Tumor Cells: A Prospective, Observational Study
NCT07112937 ·Status: RECRUITING
-
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
NCT03998202 ·Status: RECRUITING
-
The Microbrect-FFC Study
NCT06236321 ·Status: UNKNOWN ·Phase: NA
-
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
NCT05914766 ·Status: RECRUITING ·Phase: NA
-
Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer
NCT07214142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Neoadjuvant Chemoradiotherapy Combined With Immunotherapy and Anti-angiogenesis in Treating Locally Advanced Rectal Cancer
NCT07134218 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Neoadjuvant Metformin in Association to Chemoradiotherapy for Locally Advanced Rectal Cancer
NCT02473094 ·Status: TERMINATED ·Phase: PHASE2
-
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer
NCT04428905 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Neoadjuvant Radiotherapy Followed by Transanal Endoscopic Microsurgery for T1-T2 Extraperitoneal Rectal Cancer
NCT02127645 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy.
NCT00210106 ·Status: COMPLETED ·Phase: NA
-
Local Excision of Clinical T3 Rectal Adenocarcinoma Showing Major Response(ycT0-1) After Neoadjuvant Chemoradiotherapy
NCT02490709 ·Status: UNKNOWN ·Phase: PHASE2